Flora Stavridi

Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients

Eirini Papadopoulou, Katerina Tsantikidi, Vasiliki Metaxa-Mariatou et al. · PLoS ONE · 2019 · 56 citations · Full text

Medicine, Molecular Medicine, Oncology +17

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

Naureen Starling, Alicia Okines, David Cunningham et al. · British Journal of Cancer · 2009 · 24 citations · Full text

Medicine, Oncology, Surgery +17

Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer

Mark Linch, Flora Stavridi, Jane Hook et al. · Gynecologic Oncology · 2008 · 21 citations

Medicine, Gynecology, Oncology +13

alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies

Triantafyllia Κoletsa, Flora Stavridi, Mattheos Bobos et al. · BMC Clinical Pathology · 2014 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +11

A phase I study of daily BIBW 2992, an irreversible EGFR/HER-2 dual kinase inhibitor, in combination with weekly paclitaxel

J. Ang, Christos Mikropoulos, Flora Stavridi et al. · Journal of Clinical Oncology · 2009 · 12 citations

Medicine, Oncology, Pharmacology +16